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Abstract
Background:  Mycoplasmas are the smallest microorganisms capable of self-replication. Our
previous studies show that some mycoplasmas are able to induce malignant transformation of host
mammalian cells. This malignant transformation is a multistage process with the early infection,
reversible and irreversible stages, and similar to human tumor development in nature. The purpose
of this study is to explore mechanisms for this malignant transformation.
Methods:  To better understand mechanisms for this unique process, we examined gene
expression profiles of C3H cells at different stages of the mycoplasma-induced transformation using
cDNA microarray technology. A total of 1185 genes involved in oncogenesis, apoptosis, cell
growth, cell-cycle regulation, DNA repair, etc. were examined. Differences in the expression of
these genes were compared and analyzed using the computer software AtlasImage.
Results: Among 1185 genes screened, 135 had aberrant expression at the early infection stage,
252 at the reversible stage and 184 at the irreversible stage. At the early infection stage, genes with
increased expression (92 genes) were twice more than those with decreased expression (42
genes). The global gene expression at the reversible stage appeared to be more volatile than that
at any other stages but still resembled the profile at the early infection stage. The expression profile
at the irreversible stage shows a unique pattern of a wide range of expression levels and an
increased number of expressing genes, especially the cancer-related genes. Oncogenes and tumor
suppressors are a group of molecules that showed significant changes in expression during the
transformation. The majority of these changes occurred in the reversible and irreversible stages. A
prolonged infection by mycoplasmas lead to the expression of more cancer related genes at the
irreversible stage.
Conclusion: The results indicate that the expression profiles correspond with the phenotypic
features of the cells in the mycoplasma induced transformation process. The early mycoplasma
infection stage shares a common phenomenon with many other acute infections, genes with
increased expression significantly outnumbering those with decreased expression. The reversible
stage is a transition stage between benignancy and malignancy at the molecular level. Aberrant
expression of oncogenes and tumor repressors plays a key role in mycoplasma-induced malignant
transformation.
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Background
Mycoplasmas are a group of the smallest free-living organ-
isms that commonly infect or colonize the oral-respira-
tory and urogenital tracts of humans and animals. These
wall-free mycoplasmas are among the few prokaryotes
that can grow in close interaction with mammalian cells,
often silently, for a long period of time [1]. Our previous
studies have revealed that chronic and persistent infection
with these seemingly low-virulence mycoplasmas could
gradually but significantly affect many important biologi-
cal characteristics of mammalian cells and even lead to
malignant transformation [2-4].
C3H cells (C3H10T1/2), a murine embryonic cell line,
rarely undergo spontaneous transformation, and are one
of the few standard test systems for studying potential car-
cinogenic agents in animals or humans [5]. M. fermentans
and  M. penetrans are the most common mycoplasmas
associated with HIV infection or AIDS, and have been pro-
posed to play a co-factor role in the disease process [6].
Our earlier study revealed that chronic infections with M.
fermentans and M. penetrans induced malignant transfor-
mation of C3H cells [3]. However, as opposed to earlier
reports of mycoplasma-associated malignant cell transfor-
mation [7,8], our study showed that infection by M. fer-
mentans  or  M. penetrans did not lead to rapid
transformation of C3H cells. Instead, the mycoplasma-
mediated malignant cell transformation required a pro-
longed period of infection with these organisms (a long
latency) and was evidently a multistage process. Although
C3H cells showed prominent morphological transforma-
tion after 7 weeks of mycoplasmal infections, malignant
properties associated with cell transformation could be
rapidly reversed by eradicating the mycoplasma from cul-
ture with antibiotics up to 11 weeks of mycoplasmal infec-
tion (reversible stage). However, further persistent
infection beyond 18 weeks resulted in an irreversible form
of transformation that included prominent chromosomal
alteration, the ability to form tumors in animals and high
efficiency of colony formation in soft agar. At this irrevers-
ible stage, the transformed cells showed unique karyo-
typic changes and growth characteristics. The continued
presence of the transforming mycoplasmas was no longer
required for maintaining the transforming traits of the
cells [3].
The multistage transformation effect associated with
chronic  M. fermentans and  M. penetrans infections was
similarly observed in our recent studies using 32D cells, a
mouse hematopoietic cell line strictly dependent on IL-3
for their growth [2,9]. Infection with M. fermentans or M.
penetrans prevented apoptosis and effectively induced IL-3
independent growth of the cells. Prolonged infections
with these mycoplasmas eventually lead to autonomous
growth of the cells in vitro and to form tumors in mice in
the absence of either IL-3 or the transforming mycoplas-
mas [2,10]. Some strains of M. fermentans were very effec-
tive in immortalization of human peripheral blood
mononuclear cells [11], which might be linked with some
hematological malignancies.
The long latency and distinct multistage process of malig-
nant cell transformation induced by the human myco-
plasmas closely resemble human tumor development in
nature. It has provided an excellent model system for
studying molecular mechanisms of malignant cell trans-
formation. Our earlier studies of possible molecular
mechanisms revealed that over-expression of H-ras and c-
myc oncogenes was associated with malignant transfor-
mation of C3H cells [12]. On the other hand, no evidence
of integration of mycoplasmal genetic material (DNA)
could be found in the malignant C3H cells induced by
mycoplasmal infections [13]. Since many different genes
are likely involved in the malignant cell transformation, a
global analysis of the gene expression at the different
stages of mycoplasma-induced malignant transformation
is highly desired. The recently developed cDNA microar-
ray technology would allow us to effectively analyze the
expression of many genes in a short period of time
[14,15]. This technology has been used to analyze gene
expression in host cells infected with various microorgan-
isms [16,17], in virus transformed mammalian cells [18]
and in cancer tissues [19]. In this study, we used the cDNA
microarray technique to investigate the global changes of
the gene expression in C3H cells at the different stages of
the mycoplasma-induced malignant transformation. The
array analyzed changes in expression of 1,185 different
genes. Many of them have been proven to play an impor-
tant role in cell malignant transformation.
Methods
1. Induction of malignant transformation of C3H cells
Malignant transformation of mouse embryonic C3H cells
by persistent infection of M. fermentans incognitus stain
(MI) was previously described in detail [3]. In this study,
we used parallel cultures of noninfected C3H cells as the
control, C3H cells infected with M. fermentans for 1 week,
11 and 18 weeks as representatives of the early myco-
plasma infection stage and the reversible as well as irre-
versible stages of the mycoplasma-induced malignant
transformation, respectively. RNAs prepared from these
cells were used in the following analysis of gene expres-
sion profiles.
2. RNA preparation and quantification
Total RNA was prepared from C3H cells using TRIzol rea-
gent (Life Technologies, Inc., Gaithersburg, MD) accord-
ing to manufacturer's instructions [20]. Total RNA
prepared from mycoplasma-infected and non-infected
control C3H cells were treated with RNase-free DNase IBMC Cancer 2006, 6:116 http://www.biomedcentral.com/1471-2407/6/116
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(Roche Diagnostics Corporation, Indianapolis, IN) to
remove residue genomic DNA. The RNA was then
extracted with phenol/chloroform/isoamyl alcohol fol-
lowed by ethanol precipitation. The integrity and concen-
tration of the purified RNA were further determined by
measuring the absorbance at 260 nm and the 260/280
absorbance ratio on a spectrophotometer and by electro-
phoresis on a 1.2% agarose gel in formaldehyde-MOPS
(3- [N-Morpholino]propanesulfonic acid) buffer [4].
3. Detection of gene expression using the cDNA 
microarray technique
To study global gene expression in C3H cells during the
malignant transformation process, radioactively labeled
cDNA prepared from DNase treated total RNA of C3H
cells was selectively hybridized onto high density arrays of
membrane-bound double strand cDNAs on the Atlas
Mouse Cancer 1.2 Array (Clontech Laboratories, Inc., Palo
Alta, CA). This array contains cDNA of 1,185 different
genes known to be actively involved in cell transforma-
tion, cell adhesion and mobility, cell cycle, stress
response, DNA damage repair, transcription, translation,
signal transduction, basic metabolism, trafficking/trans-
portation/targeting as well as extracellular matrix pro-
teins. The detail description of the array information
could be found in Clontech's Atlas Mouse Cancer 1.2
Array user manual.
Preparation of radioactively labeled cDNA probes and
subsequent hybridization to the cDNA arrays were con-
ducted as recommended by the manufacturer, using rea-
gents provided by the manufacturer. In brief, for each
array, 2.5 µg of total RNA were reverse-transcribed with
MMLV reverse transcriptase in the presence of 35 µCi of
[α-P32] dATP. The radioactive cDNA probes were purified
using NucleoSpin extraction spin columns. The probes
with total cpm >2 × 106 were used for the subsequent
hybridization. The hybridization of the radioactively
labeled probes to the Atlas arrays was conducted in rolling
tubes in a Micro Hybridization Oven at 68°C overnight.
The arrays were washed with 2× SSC containing 1% SDS 4
times and with 0.1 × SSC containing 0.5%SDS once at
68°C, each for 30 minutes, followed by a final wash with
2× SSC at room temperature for 5 min. The membranes
were exposed to BioMax X-ray films with BioMax Tran-
screen HE intensifying screens (Eastman Kodak Com-
pany, Rochester, NY). The films were then developed and
scanned on an Epson scanner.
The hybridization of the probes prepared from total RNA
of C3H cells at different transformation stages to cDNA
microarrays of the same batch was carried out under iden-
tical conditions. Subsequent wash steps, generation of
image data and data analysis were performed in parallel.
This approach facilitated the direct comparison of gene
expression level between mycoplasma-infected cells and
noninfected control cells.
4. Array data analysis
The Image data from microarray hybridization were fur-
ther analyzed using AtlasImage™ 2.01 software (Clontech
Laboratories, Inc.). A gene with a specific intensity (signal
intensity minus local background intensity) higher than
5000 density units (cutoff level) was defined as expressed.
In order to compare the gene expression profile of two
arrays, global normalization was calculated by the sum
method. Differences of signal intensity minus background
on each array were added for all values over background.
Afterwards, the normalization coefficient was determined
by calculating the ratio of array 1 sum and array 2 sum.
After normalization, background was subtracted. The
adjusted intensity of a corresponding gene on two arrays
was compared. The ratio threshold was set at 2 and the dif-
ference threshold was set at 5000 units.
5. Materials and chemicals
Cell culture medium RPMI 1640 and fetal bovine serum
were purchased from Life Technologies, Inc. SP4 medium
for mycoplasma culture was prepared in our laboratory
[21]. Tissue culture plastic wares were from Nalge Nunc
International, Rochester, NY. [α-32P] dATP (specific activ-
ity >3,000 mCi/mM) was from ICN Biomedicals, Inc.
Aurora, OH. Ciprofloxacin was from Bayer Corporation,
West Haven, CT. All general chemicals were purchased
from Sigma-Aldrich, St. Louis, MO.
Results
Gene expression in C3H cells at different stages of 
malignant transformation induced by mycoplasmal 
infections
An Atlas cDNA expression membrane microarray, Mouse
Cancer 1.2 Array, was used to study expression profiles of
genes known to be associated with oncogenesis in C3H
cells at the different stages of mycoplasma-induced malig-
nant transformation. Each gene was represented on the
array as one spot containing immobilized cDNA frag-
ments. 32P-cDNA probes synthesized by the in vitro reverse
transcription from total RNA of C3H cells infected with
mycoplasmas for different periods of time and from non-
infected control cells were hybridized to the arrays. Anal-
ysis of signal intensity on the arrays showed that tran-
scripts (mRNA) of 736 genes (62.1%) out of 1185 arrayed
genes were scored as expressed in non-infected control
cells (Tab. 1). The gene expression of control C3H cells
has been measured 3 times using the same batch of RNA
and cDNA microarrays. The same expression pattern was
observed. The expression of 755 genes (63.7%) was
detected in the cells infected with M. fermentans for 1 week
(early infection stage), 748 genes (63.1%) in the cells





















































































































Table 1: Differential gene expression between control cells and cells at different stages of mycoplasma-induced malignant transformation
Gene Class Number of genes
Screened Expressed in 
control cells
Expressed and altered in cells following mycoplasmal infection
1 week 11 weeks 18 weeks
Expressed Increased Decreased Expressed Increased Decreased Expressed Increased Decreased
Apoptosis associated proteins 48 30 34 4 2 27 3 7 25 6 5
Cell adhesion receptors/proteins 100 61 60 6 1 61 9 10 69 12 3
Cell cycle associated proteins 45 34 31 2 4 26 2 9 35 2 5
Cell receptors (by activities) 162 74 90 16 5 90 26 16 70 9 14
Cell signaling, extracellular communication proteins 144 89 82 8 4 98 18 10 112 11 6
Cytoskeleton/motility proteins 59 39 41 4 3 37 8 8 51 6 7
DNA binding and chromatin proteins 44 23 29 5 1 29 6 1 31 8 0
Extracellular transport/carrier proteins 6 4 5 0 0 3 1 0 5 0 0
Extracellular matrix proteins 30 28 29 3 2 29 4 1 27 2 7
Functional unclassified 15 8 11 3 1 13 5 1 13 2 1
Intracellular transducers/effectors/modulators 253 155 158 20 6 149 26 28 201 32 10
Membrane channels, transporters and cell surface antigens 27 16 16 4 1 20 7 0 18 4 1
Metabolism-associated proteins 26 14 16 5 1 18 4 2 20 3 0
Oncogenes and tumor suppressors 65 43 46 3 1 41 6 7 53 8 2
Stress response proteins 39 24 22 1 1 21 3 2 26 2 3
Trafficking/targeting proteins 5 2 1 0 0 2 0 0 3 0 0
Transcription associated proteins 30 27 20 3 4 25 2 3 29 1 0
Translation, post-translation modification and protein turnover 87 65 64 5 6 58 8 9 74 7 5
Total 1185 736 755 92 43 748 138 114 862 115 69BMC Cancer 2006, 6:116 http://www.biomedcentral.com/1471-2407/6/116
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(72.9%) in the cells infected for 18 weeks (irreversible
stage). The specific intensity of the expressed gene spots
on the array ranged from 5008 to 65280 arbitrary units
above background. The irreversibly transformed C3H cells
(C3H/MI/P18) expressed 15% more genes than non-
infected control cells or cells at other stages of the myco-
plasma-induced malignant transformation.
Differential profiles of gene expression in control cells and 
cells at different stages of the malignant transformation
Comparison of gene expression profiles between non-
infected control cells and mycoplasma-infected C3H cells
at different stages of transformation revealed that 92 genes
(7.76% of arrayed genes) were significantly up-regulated
and 43 genes (3.63%) were down-regulated in C3H cells
following one week of mycoplasmal infection. After 11
weeks of mycoplasmal infection, 138 genes (11.65%)
became up-regulated and 114 genes (9.62%), down-regu-
lated. Numbers of genes with increased expression and
decreased expression were 113 (9.53%) and 69 (5.82%),
respectively, in cells infected with the mycoplasmas for 18
weeks. The distribution of genes with altered expression at
different stages of cell transformation is shown in Table 1,
according to their associated functions.
Further analysis of the gene expression in C3H cells
revealed that the expression of 44 genes was altered in
cells at all three stages of malignant transformation fol-
lowing mycoplasmal infections. Some changes of the gene
expression occurred in cells at two different stages and
others only at a single stage of the transformation (Fig. 1).
Compared with the gene expression in control cells, more
genes are up-regulated in mycoplasma-infected cells. The
majority (97.02%) of the alterations that occurred in two
or three stages had the same direction (either increased or
decreased expression). An example of differential expres-
sion of C3H cells during mycoplasma-induced malignant
transformation is shown in Fig. 2. Expression of many
genes, such as extracellular matrix protein 1, remained
unchanged at the different stages of the mycoplasma-
induced transformation (Fig. 2, a). The mRNA level of
procollagen III α1 subunit decreased transiently in cells
infected by mycoplasmas for 11 weeks (Fig. 2, b). The
expression of fibrillin 1, on the contrary, markedly
increased in cells infected by mycoplasmas for 1 week
then returned to the original low level in the later phase of
mycoplasmal infection (Fig. 2, d). On the other hand, the
expression of T-complex protein 1 epsilon subunit was
quickly elevated at the early stage of mycoplasmal infec-
tion and remained high in C3H cells infected by the myc-
oplasmas for 18 weeks (Fig. 2, c).
Global comparison of gene expression profiles among 
control cells and cells at different stages of mycoplasma-
induced transformation
In order to search for characteristic gene expression pro-
files of C3H cells for individual stages during the myco-
plasma transformation, gene expression levels were
globally compared among control cells and cells infected
with the mycoplasmas for different lengths of time. As a
result, the expression levels for each individual gene in
C3H cells from 2 differently treated cultures formed a sin-
gle dot (expression signature) at the cross point on scatter
graphs. If expression levels of a given gene from two dif-
ferent samples are the same, the expression signature
should be on the 45° hypothetic line of the chart. If the
expression profiles from two different samples are similar,
the correlation line that is plotted from all expression sig-
natures should be near 45° and all signatures should be
on or close to this line (Fig. 3).
The scattered dots of the gene expression from 2 different
batches of control cells that were cultured for different
periods of time were curve-fitted and showed a good lin-
ear correlation around 45° and a high correlation coeffi-
cient, which represent a high similarity of the gene
expression profiles between the two batches of control
cells. However, the gene expression profiles were signifi-
cantly different between the non-infected control cells
and the cells infected by M. fermentans for different periods
of time (Fig. 3). At the early stage of mycoplasmal infec-
tion, the number of genes (92) with increased expression
was twice more than that (43) with decreased expression
(Table 1). This caused the left shift of the correlation line
Venn diagram of genes with aberrant expression in C3H cells  at different stages of the mycoplasma-induced malignant  transformation Figure 1
Venn diagram of genes with aberrant expression in C3H cells 
at different stages of the mycoplasma-induced malignant 
transformation. Circles symbolize individual stages of myco-
plasma-induced malignant transformation. Numbers in a cir-
cle stand for genes expressed at that stage at least 2 fold 
differentially when compared to those expressed in control 
cells, while numbers in shared areas of circles represent 
genes with altered expression occurred at those stages.BMC Cancer 2006, 6:116 http://www.biomedcentral.com/1471-2407/6/116
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on the scatter plot (Fig. 3A). The correlation coefficient (r)
was 0.695. However, the expression signatures between 1
week-infected and the non-infected control C3H cells did
not scatter widely. The expression signatures on the scatter
graphs between control cells and infected cells were
increasingly more scattered and the correlation line grad-
ually right-shifted with continuing mycoplasmal infection
(Fig. 3B and 3C). The correlation coefficients between
control cells and cells infected for 11 weeks and 18 weeks
were 0.602 and 0.585 respectively. Surprisingly, a high
correlation (r = 0.784) in the gene expression profile was
observed between cells infected with mycoplasmas for 1
week and 11 weeks (Fig. 3D). The correlation line was
near 45°. By contrast, more significant differences in the
expression profiles between cells infected for 1 week and
18 weeks (Fig. 3E, r = 0.602) as well as between cells
infected for 11 weeks and 18 weeks (Fig. 3F, r = 0.698)
were observed.
Alteration in the expression of cancer-associated genes 
during mycoplasma induced malignant transformation
We specifically examined the expression profile of various
oncogenes and tumor suppressor genes. Among a total of
65 oncogenes and tumor suppressor genes screened, 43
Kinetic changes in the gene expression during mycoplasma-induced transformation Figure 2
Kinetic changes in the gene expression during mycoplasma-induced transformation. Total RNAs were prepared from C3H 
cells infected with M. fermentans for 1 week (wk), 11 weeks (wks) and 18 wks as well as from noninfected control cells (Ctrl). 
Radioactive cDNA probes prepared from these RNAs were hybridized to the Mouse Cancer 1.2 Arrays. Results were 
obtained by the autoradiography. Four autoradiographic pictures in Panel A represent the same areas on the arrays hybridized 
with cDNA probes prepared from control cells and cells infected with the mycoplasmas for 1 wk, 11 wks and 18 wks. Dots 
pointed by arrows are individual genes: a. Extracellular matrix protein 1; b. Procollagen III α1 subunit; c. T-complex protein 1 
epsilon subunit and d. Fibrillin 1. Panel B is graphic depiction of kinetic changes of the expression of the above 4 genes during 
mycoplasma-induced transformation process. Scale on Y axis is the relative gene expression level and X axis is different stages 
of the mycoplasma induced transformation.BMC Cancer 2006, 6:116 http://www.biomedcentral.com/1471-2407/6/116
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were expressed in the non-infected control C3H cells. The
number of expressed oncogenes and tumor suppressor
genes was 46 in cells infected with the mycoplasmas for 1
week and 41 in cells infected with the mycoplasmas for 11
weeks. However, the number was significantly increased
in the irreversibly transformed cells. Fifty-three oncogenes
and tumor suppressors were expressed in the C3H cells
following 18 weeks of mycoplasmal infection (Table 1).
Compared to the expression level of these cancer-associ-
ated genes in control cells, one oncogene (myeloblastosis
oncogene-like 2) was over-expressed and one (transfor-
mation-related protein 53, Trp 53 or p53) was under-
expressed in cells at the early infection phase. Expression
of two other oncogenes (G-protein coupled receptor 25
and chemokine-like receptor 1) was up-regulated from
non-expression level in control cells to a level 3 fold
higher than the cutoff expression level at the early infec-
tion stage and maintained at this high level of expression
throughout the entire transformation process. Expression
of the tumor suppressor p53, a most extensively studied
tumor suppressor, was decreased in this entire transfor-
mation process induced by mycoplasmal infection. The
number of oncogenes/tumor suppressor genes with
detectable expression in cells infected with mycoplasmas
Comparison of gene expression profiles among control C3H cells and M. fermentans infected cells at different stages of the  malignant transformation Figure 3
Comparison of gene expression profiles among control C3H cells and M. fermentans infected cells at different stages of the 
malignant transformation. Gene expression in the cells was screened by the cDNA microarray technique. Expression profiles 
were generated by the analysis of the gene expression data using the computer software AtlasImage™ version 2.01. A compar-
ison of these profiles was made among the control cells and infected cells. The graphs were plotted as the expression level at 
one stage over that at another stage for each of the 1185 genes examined. Correlation lines were plotted by the computer-fit-
ting. The scales on both X- and Y-axis represent gene expression level using arbitrary density units of each dot. Panel A, Con-
trol cells vs. cells infected for 1 week (wk); Panel B, Control cells vs. cells infected for 11 weeks (wks); Panel C, Control cells 
vs. cells infected for 18 wks; Panel D, Cells infected for 1 wk vs. for 11 wks; Panel E, Cells infected for 1 wk vs. for 18 wks and 
Panel F, Cells infected for 11 wks vs. for 18 wks.BMC Cancer 2006, 6:116 http://www.biomedcentral.com/1471-2407/6/116
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for 11 weeks (41 genes) appeared to be fewer than those
expressed at other stages of mycoplasmal infection. How-
ever, the number of genes with aberrant expression in this
particular stage was the highest among the three stages. Six
genes were up-regulated and 7 down-regulated in this
stage (Table 2). In the 18-week mycoplasma-infected cells,
6 oncogenes and 2 tumor suppressor genes were over-
expressed, 1 oncogene and 1 tumor suppressor gene were
under-expressed (Table 2).
Discussion
The present study attempts to further elucidate the molec-
ular mechanisms that may play a critical role in the com-
plex malignant cell transformation process, using a
mycoplasma-oncogenesis model we previously devel-
oped. The in vitro model system shares many important
characteristics found in the development of human can-
cer, including long latency and multistages of progression
[3]. The newly available microarray technique allows us to
compare the expression profiles of more than 1000 genes
that are likely to be associated with oncogenesis in cells at
different stages of malignant transformation induced by
mycoplasmal infection. Two groups of molecules, the
oncogenes and tumor suppressor genes, and apoptosis-
associated genes, which could be of particular importance
in the development and progression of malignant tumors,
were included in this study.
At the early stage of mycoplasmal infection (the 1st week),
C3H cells responded with a gene expression profile often
seen in cells following acute microbial infections [22-25],
many more genes with increased expression than genes
with decreased expression. As a result, a significant left
shift of the correlation line on the scatter graph of the gene
expression was noted in Fig. 3. About half of the over-
expressed genes were related to cell signaling (receptors,
cell signaling and intracellular transducers/effectors/mod-
ulators, Table 1). Thus, despite the seemingly unapparent
infections of mycoplasmas in culture (and in vivo), mam-
malian host cells evidently had a strong response and pro-
duced a host of signaling molecules to coordinate
messages that were important for the cells' adaptation to
the new environment.
C3H cells at the reversible stage of transformation, follow-
ing 11 weeks of mycoplasmal infection, were apparently
in a transitional phase between benignancy and malig-
nancy. Eradicating the transforming mycoplasmas from
the culture with antibiotics could reverse all the malignant
phenotypes of C3H cells. The gene expression profile of
Table 2: Alterations of the expression of oncogenes and tumor suppressors in C3H cells during mycoplasmal induced malignant 
transformation
Gene/Protein Name Classification Change of the expression at different stages
GenBank 1 wk 11 wks 18 wks
Casitas B-lineage lymphoma Oncogene X57111 2.23
Villin 2 Oncogene X60671 2.15
FBJ osteosarcoma oncogene Tumor suppressor V00727 Down
G-protein coupled receptor 25 Oncogene U39827 Up Up Up
Chemokine-like receptor 1 Oncogene U79525 Up Up Up
SWI/SNF related, matrix associated, actin dependent regulator of 
chromatin, subfamily b, member 1
Tumor suppressor AJ011739 0.49
Notch gene homolog 4 (Drosophila) Oncogene M80456 Down
Lymphoid blast crisis-like 1 Oncogene U28495 Up
Myeloblastosis oncogene-like 1 Oncogene L35261 Down
Myeloblastosis oncogene-like 2 Oncogene X70472 3.20 2.94
Neurofibromatosis 2 Tumor suppressor L27105 2.65
Retinoblastoma-like 1 (p107) Tumor suppressor U27177 Down
Transformation related protein 53 Tumor suppressor K01700 0.39 0.22 0.42
RAB17, member RAS oncogene family Oncogene X70804 Up
RAB24, member RAS oncogene family Oncogene Z22819 Up Up
Src homology 2 domain-containing transforming protein C1 Oncogene U15784 Down
SKI-like Oncogene U36203 Down
Vav 1 oncogene Oncogene X64361 Up Up
1. The comparison was made by dividing the gene expression level in control cells by that in cells infected with mycoplasmas for 1 week (wk), 11 
weeks or 18 weeks (wks).
2. The ratio ≥ 2.0 or ≤ 0.5 was defined as a significant increase or decrease when expression levels of a given gene in both samples were greater 
than the cutoff level, 5000 density units.
3. "Up" means that the adjusted intensity of a gene in control cells is below 5000 units (a cutoff line for expression), while the adjusted intensity of 
this gene in mycoplasma infected cells was 5000 units above the cutoff level. The meaning of "Down" is vise verse. The blank means no significant 
change.BMC Cancer 2006, 6:116 http://www.biomedcentral.com/1471-2407/6/116
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C3H cells at this specific stage was more volatile and
appeared to reflect a transitional phase with more genes
having aberrant expression than at any other stages during
the mycoplasma-induced malignant transformation. On
the other hand, a comparison of gene expression levels
between cells at the early mycoplasma infection stage and
at the reversible stage revealed that the correlation line
was at nearly 45° and expression signatures (dots) were
distributed relatively close to the line (Fig. 3D). This scat-
ter distribution of the gene expression signatures sug-
gested that the gene expression pattern at the reversible
stage in general still mostly resembled that at the early
mycoplasma infection stage. Many studies have shown
that malignant phenotypes induced by quantitative
changes of oncogene(s) could be reversed by interrupting
the activation of causative oncogene(s) [26]. Our earlier
study revealed that eradication of mycoplasmas from cell
cultures with an antibiotic would abolish the aberrant
expression of c-myc and H-ras and reverse all of the malig-
nant properties of C3H cells at this stage [12]. These data
support our theory that malignant phenotypes of the cells
at the reversible stage might be caused by quantitatively
aberrant expression of certain oncogenes and tumor sup-
pressors in the response to chronic mycoplasmal infec-
tion.
C3H cells became irreversibly or permanently trans-
formed following 18 weeks of mycoplasmal infection and
gained the ability to form tumors in animals and colonies
in soft agar. These cells were no longer dependent on the
continuing presence of mycoplasmas for maintaining
their malignant properties [3]. Our present study revealed
that cells at this stage had the highest gene expression rate
among the 3 different stages in the transformation process
(Table 1). However, the number of genes with altered
expression actually decreased 27% from that at the revers-
ible stage (Table 1). A comparison of gene expression pro-
files between control cells and cells at the 3 three
progressive stages of the transformation showed that the
correlation lines on the scattered gene expression graphs
were gradually right-shifting (Fig. 3A, 3B and 3C). The
correlation coefficients were gradually decreasing.
Although the correlation line in the gene expression scat-
ter plot between the control cells and cells at the irrevers-
ible stage was near 45° (Fig. 3C), the expression
signatures were more scatter than those at any other stages
of the transformation process. These collective results sug-
gest that the gene expression profile at the irreversible
stage might be changed from a volatile status at the revers-
ible stage to a relatively stable status that is far more dif-
ferent from that of the noninfected control cells. The
newly established gene expression pattern at the irreversi-
ble stage may provide essential material basis for a new set
of interactions of molecules, which support the stable
malignant phenotypes of the transformed cells.
The cells at the irreversibly transformed stage also had the
highest expression rate of cancer-related genes during the
mycoplasma-induced malignant transformation (Table
1). Increase of oncogene expression and decrease of tumor
suppressor genes expression at the reversible stage (Table
2) seems to provide a relatively straightforward explana-
tion for the mycoplasma mediated malignant transforma-
tion. However, we also found decreased expression of 4
oncogenes at the reversible stage and increased expression
of one tumor suppressor at the irreversible stage. A similar
phenomenon was also observed in the expression profile
of apoptosis associated genes (Data not shown). Muta-
tion(s) in these molecules could be responsible for the
decreased oncogene expression and increased tumor sup-
pressor gene expression in the transformed cells. The
mutation could alter physiological functions of tumor-
and apoptosis-associated genes. The host cells might com-
pensate the normal functions of the affected molecules by
adjusting their expression levels. This might be the case in
the mycoplasma-induced transformation. Chronic myco-
plasmal infection could cause the genetic instability and
changes in the genetic material (DNA) of host cells
[2,3,11].
There are tens of thousand of different molecules and
hundreds of biochemical pathways in mammalian cells.
Over-expression or down-regulation of a single molecule
that plays an important role in the control of cell prolifer-
ation could evidently alter the balance of the entire cell
physiological network and lead to malignant transforma-
tion [27,28]. We believe that prolonged over-expression
and/or down-regulation of a group of important mole-
cules would likely change the critical balance of physio-
logical networks in cells chronically infected by
mycoplasmas and result in malignant cell transformation.
The present microarray study has allowed us to identify
changes of expression (up-regulated and down-regulated)
of many important oncogenesis-associated genes at the
different stages of mycoplasma-mediated cell transforma-
tion. We believe that the pattern of gene expression profile
alterations observed in our mycoplasma-induced trans-
formation model might be similar to those found in many
transformation models induced by transforming microor-
ganisms. However, due to the differences between the
transforming microorganisms, alterations of many indi-
vidual genes observed in this study could be unique to the
mycoplasma-induced transformation process. Therefore,
more work is needed to identify genes specific for myco-
plasma-induced transformation and which genes are truly
responsible for the progression of this complex process.
The further challenge is to elucidate how the aberrant
expression of these genes in cells would cause permanent
or constitutive activation of certain oncogenes and leads
to the irreversible malignant transformation.BMC Cancer 2006, 6:116 http://www.biomedcentral.com/1471-2407/6/116
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Conclusion
This study reveals different gene expression profiles of
C3H cells at different stages of the mycoplasma-induced
malignant transformation. The results indicate that these
expression profiles correspond with the phenotypic fea-
tures of the cells in the mycoplasma induced transforma-
tion process. The early mycoplasma infection stage shares
a common phenomenon in the gene expression profile
with many other acute infections, genes with increased
expression outnumbering those with decreased expres-
sion. The reversible stage is relatively unstable and chaotic
with the highest number of altered genes. Its profile
reflects the nature of the transition between benignancy
and malignancy at the molecular level. The expression
profile at the irreversible stage shows a unique pattern of
a wide range of expression levels and an increased number
of expressing genes, especially the cancer-related genes.
Aberrant expression of oncogenes and tumor repressor
might play a key role in the mycoplasma-induced malig-
nant transformation.
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